NVAX Cup and HandleNVAX is showing some strength to push upward toward the $14 level. At that point it could break out reaching back to the $16 level. A cup and handle rounding formation is happening. Looking for the handle breakout.
NVV1 trade ideas
NVAX RetestNVAX restested its breakout level of $10 and held. I was lucky enough to get in at the $10.5 range before it continued further upside. Looking for a quick target of $14 due to its volatility before earnings.
$NVAX Dances While the Music Plays, But What's Next?NVAX ramped on the squeeze as crowd psychology and algorithmic logic took hold in the market crash last week. But this company has as much chance of participating in the actual vaccine as my aunt's family chicken soup recipe. We look for the fade.
NVAX - closing gaps! - fast down as mentioned... earlyNVAX - closing gaps! - fast down as mentioned... early. DROP HARD. as was mentioned it would do. early monring. (Now lets see where it goes from here after 10am.)
___________________________________
Disclaimer:
Always do your own due diligence, full research, and homework, and consult with your own licensed investment professional before any investments. Any comments and analysis seen here are personal opinions, and we are not registered or licensed in any jurisdiction whatsoever to provide any investing advice. Any analysis, charting and comments should never be used for the purposes of assisting in any advisory decisions with any stock purchase or sale, and never to be used on the basis of making any kind of investment decisions. It is for the sole purposes of opinions and thoughts only of the markets. Thank you.
Pharma Stocks Don't move MuchWell for some reason the News is Killing the Market, I am down 60% Today, so decided to look at things with a different Light. Which ones Move differently depending on the Hype / News that is in our Ears.
Got this one for $10 and next day it was $16 that might be the top for this one but Maybe not? I did not draw on the Chart but you can see it took off like a Rocket. There are Three Stocks that are dealing directly with Coronavirus this one was moderate price so I went with this guy. If it gets close to some of their previous levels could be interesting month. Just thought I would share.
Have a good day and don't forget to Wash your Hands.
Novavax (NVAX) - Vaccine Testing - SARS, MERS, SARS-CoV-2 (2019)This is an interesting idea based on outbreaks of SARS, MERS, and SARS-CoV-2 (2019).
Novavax successfully created vaccines for SARS, MERS, and are on track to create one for SARS-CoV-2 (2019) - ir.novavax.com
Vaccine in development for SARS-CoV-2 (2019): seekingalpha.com
Is this a good investment? If the vaccination is successful and/or coronavirus outbreak continues, it could trend upwards significantly.
Disclaimer: This is not financial advice. Just my own opinion based on research.
Important Notes: For your own safety, the CDC recommends you WASH YOUR HANDS FREQUENTLY. COVER YOUR MOUTHS WHEN YOU COUGH/SNEEZE.
NVAX --- Jumped $15 -promised --- NOW sold someposition for NOW NVAX --- Jumped!!! from pre-hours trading. on OPEN. ---- CAN KEEP GOING UP ---- also - Take some prfts now to be safe -- IMO.
NOW sold the position for NOW taking the very nice profits off the table....
and then wait and see next move... The technical indicators shown that it could quickly reach that high and it did ---- now since it went so soon need to wait and see....methods in DAY TRADING. IMO.
It could certainly rise more -- (BUT TAKING SURE PROFITS HERE -- IN THIS CASE IS NEVER EVER WRONG!)
It may need to close gaps from the quick rise.
Thanks
E.
___________________________________
Disclaimer:
Always do your own due diligence, full research, and homework, and consult with your own licensed investment professional before any investments. Any comments and analysis seen here are personal opinions, and we are not registered or licensed in any jurisdiction whatsoever to provide any investing advice. Any analysis, charting and comments should never be used for the purposes of assisting in any advisory decisions with any stock purchase or sale, and never to be used on the basis of making any kind of investment decisions. It is for the sole purposes of opinions and thoughts only of the markets. Thank you.
NVAX --- Great movement!! but -- caution is advised always.....NVAX --- Great movement!! Very nice chart developing here --- but be very cautious.... I believe it will climb up to the 13.90 range... (after hours it already climbed and touched in the $13.00+ dollar range before it may reverse sharply and come straight down. Alwasy be very careful with any Pharmaceutical stocks --- as they can change direction and wipe everything out in a heartbeat. Currently Novavax NVAX (along with a few others) are in processes of trying to develop vaccines for the VIRUSES...and yes currently helping with the coronavirus. (Trying to -- anyways).
Very finickly stocks...If not successful in developments in their search ---- High interest with a pump and dump type of action almost...
It can be a nice stock play if you go --- in and out --- IMO.
Not for the faint of heart. You need to know where to get in and out ---and constantly review the pattern...as it develops in front of you. Day trading at best.
Be careful.. a warning to you.
___________________________________
Disclaimer:
Always do your own due diligence, full research, and homework, and consult with your own licensed investment professional before any investments. Any comments and analysis seen here are personal opinions, and we are not registered or licensed in any jurisdiction whatsoever to provide any investing advice. Any analysis, charting and comments should never be used for the purposes of assisting in any advisory decisions with any stock purchase or sale, and never to be used on the basis of making any kind of investment decisions. It is for the sole purposes of opinions and thoughts only of the markets. Thank you.
NVAX -- Crazy climb!! In try to finding vaccine....NVAX -- Crazy climb!! In a try to reach a vaccine.... ZACKS pick The company’s expected earnings growth rate for the current year is 46% compared with the Zacks Medical - Biomedical and Genetics industry’s projected earnings growth of 8.1%. Novavax, Inc. NVAX is a late-stage biotechnology company that focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Post the virus outbreak, the company has launched a program for the coronavirus vaccine. Novavax already boasts success in vaccine development for the MERS and SARS strains.
Be careful with Pharmicuticals... can be great BUT can reverse VERY VERY quickly. Buy moderate lows. Can be shorted because of this.
SPIKING ON NEWS!! TODAY.
___________________________________
Disclaimer:
Always do your own due diligence, full research, and homework, and consult with your own licensed investment professional before any investments. Any comments and analysis seen here are personal opinions, and we are not registered or licensed in any jurisdiction whatsoever to provide any investing advice. Any analysis, charting and comments should never be used for the purposes of assisting in any advisory decisions with any stock purchase or sale, and never to be used on the basis of making any kind of investment decisions. It is for the sole purposes of opinions and thoughts only of the markets. Thank you.
$NVAX Still Seems Like a Short in the MakingNVAX is one, of all the COVID-2019 movers, that we think is most likely to end up being a great short down the line.
The long-term trajectory speaks of numerous failures to execute in clinical development, and the company is not part of the inside clique with funding to solve the virus vaccine puzzle. But it's up almost 100% since the news first broke last month.
$NVAX Coronavirus Pop May Be Rolling Over AlreadyNVAX
The "inevitability bell" may be starting to ring on this one. We called it short a few days ago -- and 7% higher. And now we may be seeing this start to play along. If short with us here, stops should be set in place in the $8.75 area to fence off the unbounded squeeze risk.
Novavax Coronavirus StockNovavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Its vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
longGap play. NVAX is in stage 3 of a trial to treat influenza. This is a huge money maker. Net Income has been on a steady climb up. with a solid product this could take off. has broken the 200 day EMA for the first time in a long time. slight pull back at the moment.
$NVAX Elevates on Wuhan Fever.. But Will it Last?NVAX
NVAX breaking out as a notable "Wuhan Coronavirus" play after company hit the wires with dev plan for vaccine candidate.
But the company has a history of under-delivering in key moments. This is a momo headline play, but after the fever breaks, so will the stock.
NVAX coronavirus panic.NVAX coronavirus panic. Currently, several biotech shares rose significantly yesterday. The driving force is a fundamental fear of the coronavirus. NVAX is one of the potential candidates who can isolate and solve the problem. The fair value of NVAX stock is currently around USD 11.5. Technically, the stock price is in the right place. But what about panic? Is technology down there? ... Not sure. With braver target prices, the next upswing can be exploited. Let's start with the most basic target price rule. The target price is the sum of the closing value of the given trading time frame and the ATR of the two farthest moving averages measured at the closing values. Where can we be brave here? There to raise the timeframe to W1. In this timeframe, we generate a closing value ATR and this can give you a target price level. So if we calculate a target price using W1 ATR calculation, then the target price can be 33.6usd. A 231% increase from the current level. This analysis is highly speculative. But in panic it can easily work.
NovaMax - a short term play?A comany that is capable of designing a vaccine for coronavirus.
It is difficult to say whether the price spike is due to the capability or their recent drug clinical trials succeeding.
NOVAVAX: Will we see another low?Seems novavax is repeating correction waves!!!! Looking forward for a big rally above 5.01. Will novavax turns around?
posible trend change with good upsidenvax maybe a good long term runner.
could make a setback before testing upper canal.
make your protections.
NAVXNVAX’s innovation outlook is neutral based on a current score of 55 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is neutral. Over the past 4 quarters NVAX beat earnings estimates 1 time. For more analysis and articles visit our website .
NVAX possibly start up trendNVAX possibly start up trend. wait for 123 confirmation. I also watcing this one
